Provided by Tiger Fintech (Singapore) Pte. Ltd.

Replimune Group Inc.

8.77
+0.77009.63%
Pre-market: 8.990.2250+2.57%04:03 EDT
Volume:1.35M
Turnover:12.00M
Market Cap:675.03M
PE:-2.96
High:9.33
Open:7.86
Low:7.83
Close:8.00
Loading ...

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
12 Apr

Is Replimune Group (NASDAQ:REPL) A Risky Investment?

Simply Wall St.
·
11 Apr

BRIEF-Replimune Group Appoints Michael Goller To Board, Increases Board Size To Ten

Reuters
·
08 Mar

Replimune Group Inc - Appoints Michael Goller to Board, Increases Board Size to Ten

THOMSON REUTERS
·
08 Mar

BRIEF-Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
08 Mar

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
08 Mar

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
08 Mar

Replimune Group Is Maintained at Overweight by JP Morgan

Dow Jones
·
27 Feb

Analysts Offer Insights on Healthcare Companies: Waters (WAT), Alkermes (ALKS) and Replimune Group (REPL)

TIPRANKS
·
13 Feb

Replimune Group Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
13 Feb

Replimune price target raised to $22 from $21 at H.C. Wainwright

TIPRANKS
·
13 Feb

Replimune Group, Inc. : H.c. Wainwright Raises Target Price to $22 From $21

THOMSON REUTERS
·
13 Feb

Navigating Uncertainty: Replimune Group’s Strategic Challenges Amid Clinical Trials and Global Risks

TIPRANKS
·
13 Feb

Wedbush Raises Replimune Group's Price Target to $19 From $16, Keeps Outperform Rating

MT Newswires Live
·
13 Feb

Replimune price target raised to $19 from $16 at Wedbush

TIPRANKS
·
13 Feb

Replimune price target raised to $21 from $18 at Leerink

TIPRANKS
·
13 Feb

Replimune Group Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
12 Feb

Replimune Group Q3 EPS $(0.79) Misses $(0.71) Estimate

Benzinga
·
12 Feb

BRIEF-Replimune Group Q3 Net Income USD -66.34 Million

Reuters
·
12 Feb

Replimune Group Q3 Basic EPS USD -0.79

THOMSON REUTERS
·
12 Feb